Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effects of Tirzepatide on Coronary Plaque Lipid Content and Myocardial Microvascular Function in Overweight and Obese People With Coronary Disease - The IDEAL-COR Study

NCT06606821 is registered in ClinicalTrials.gov with Tina Vilsbøll as lead sponsor.

NCT NCT06606821
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06606821 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effects of Tirzepatide on Coronary Plaque Lipid Content and Myocardial Microvascular Function in Overweight and Obese People With Coronary Disease - The IDEAL-COR Study
Lead sponsor
Tina Vilsbøll
Phase
Phase 4
Overall status
Recruiting
Start date
October 1, 2024
Completion date
August 1, 2028
Enrollment
124 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

atherosclerosis cardiovascular disease, chronic coronary artery disease, coronary artery disease, coronary microvascular dysfunction, overweight or obesity, stable angina pectoris